(Q47175107)

English

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

scientific article published on 19 September 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29064485

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials (English)

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29064485

1 reference

based on heuristic

inferred from title

Nathalie Grardel

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

C Piette

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Suciu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

E Clappier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Y Bertrand

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Drunat

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Girard

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

K Yakouben

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Plat

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N Dastugue

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F Mazingue

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N van Roy

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Uyttebroeck

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

V Costa

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

O Minckes

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N Sirvent

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

P Simon

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

P Lutz

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Ferster

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

C Pluchart

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Poirée

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

C Freycon

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M-F Dresse

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F Millot

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

C Chantrain

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

J van der Werff Ten Bosch

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

K Norga

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

C Gilotay

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

P-S Rohrlich

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Y Benoit

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

19 September 2017

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29064485

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

244-248

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

https://scigraph.springernature.com/pub.10.1038/leu.2017.289

0 references

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

21 January 2018

TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.289

7 January 2021

based on heuristic

inferred from DOI database lookup

Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29064485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29064485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2017.289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29064485%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47175107&oldid=2143548843"